Brad Simmons has been appointed to the newly created position of Chief Administrator, UC Davis Medical Center and Chief Operating Officer, UC Davis Health Hospital Division. The position’s responsibilities include all inpatient care for UC Davis Health.
Newsweek Magazine has named UC Davis Medical Center to its 2021 list of the “World’s Best Hospitals,” and it’s the only one so honored from the Sacramento region.
UCI Health neuromuscular disorder researchers have been awarded a prestigious $4.2 million grant to study a little understood muscle disorder in aging adults that causes asymmetric muscle weakness and severe disability. Known as sporadic inclusion body myositis (sIBM), the disease is currently untreatable. The five-year grant from the National Institute…
Registration is open for the fifth annual UCI Anti-Cancer Challenge — a virtual ride, run, walk event to raise awareness and funds for promising cancer research at the UCI Chao Family Comprehensive Cancer Center, the only comprehensive cancer center based in Orange County that is designated by the National Cancer…
Cells from individuals with Major Depressive Disorder (MDD) were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of UCSF, in collaboration with others.
In the past, UC Davis Pediatric and Cardiac Intensive Care Unit patients were dependent on in-room monitors to provide critical vitals to staff. But now, a CMN-funded monitor conversion will give kids some freedom while hospitalized.
While researchers are still striving to understand why some patients experience these “long-haul” symptoms, two UCSF clinicians from complimentary specialties have teamed up to create an integrative medicine skills program that can give such patients better tools to cope with the debilitating symptoms.
UC San Diego researchers found that the chemical inhibitor K777 reduces the coronavirus’ ability to infect cell lines by blocking human enzyme cathepsin L; clinical trials are underway.
Health Media Contacts
Find the best contact for health-related media inquiries.
